About 30-g.com

Who we are

30-g.com is published by meeco Servicios Globales S.L. (CIF B42774703), a Spanish company headquartered at Avda Cataluña 16, Alicante. We also operate the e-commerce store InjectKit.com, which sells CE-marked single-use injection supplies across the EU and UK.

We do not sell, distribute, prescribe or recommend any prescription medication. We sell only supplies — pen needles, syringes, alcohol prep pads, sharps containers and bacteriostatic water — through InjectKit.com. Editorial content on 30-g.com exists to help patients use those supplies safely, citing published guidance from regulators and peer-reviewed literature.

Why we publish

Patients on Mounjaro, Wegovy, Ozempic, Zepbound and other insulin are routinely under-supported by the systems that prescribe them. NHS surgeries time-box their consultations; private providers ship a pen and a leaflet; manufacturer websites are licensed copy that hasn’t been written for someone learning to inject themselves on a Sunday evening.

We see this every week in our support inbox at InjectKit. 30-g.com exists to publish the answers we keep emailing — but properly, with sourcing, by named people, and on a website you can find on Google instead of a confused exchange of replies.

How we work

• Sourcing. Every clinical claim in every article is traceable to a primary source: the FDA label, the EMA Summary of Product Characteristics, NICE guidance, NHS patient information, manufacturer instructions for use, or a peer-reviewed paper indexed on PubMed. Citations are inline.
• Authors. Articles are written by named members of our team (see the authors page). Their LinkedIn profiles are linked from each post. None of our writers are clinicians. We say so at the top of every YMYL piece.
• Reviews. We do not pay clinicians to add their name to an article. If we cannot rigorously source a claim ourselves, we omit it. This is a deliberate trade — see our editorial policy for the full reasoning.
• Updates. Every article carries a “Last reviewed” date and a visible changelog. When guidance changes — for example when the EMA revises a Summary of Product Characteristics — we update the page and log the change.

Who we are not

We are not a pharmacy. We are not a clinic. We are not affiliated with Eli Lilly, Novo Nordisk, Sanofi, BD, Becton Dickinson, Terumo or any pharmaceutical or device manufacturer. We do not receive payment from any drug company for editorial coverage.

We are commercially supported by our sister company InjectKit.com, which sells the supplies we write about. Articles include links to relevant InjectKit product pages where useful — for example, an article on insulin pen needle sizing will link to the 30G × 5 mm pack you might want to order. These links are clearly marked, kept to a minimum, and never crowd the editorial.

Contact

• General editorial: [email protected]
• Corrections: [email protected] (subject line: “Correction: [article URL]“)
• Press: [email protected]
• Postal: meeco Servicios Globales S.L., Avda Cataluña 16, 03002 Alicante, Spain

If you spot a factual error, please tell us. We post correction notices on the article in question and on this page’s changelog.